kai chen
1 appearance in the program
Sessions & presentations
PS38: Integrating Biomarker Discovery and Dose-optimization to Drive Drug Development Success
Presenting Author
Presentation: A Bayesian adaptive enrichment design with historical control for phase II clinical trials
Parallel · Fri, Sep 18 , 10:45 AM